Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Mesothelioma Awareness Day — September 26 — is just around the corner! It has been the driving force behind the movement to bring more attention
On July 24, 2019, the Mesothelioma Applied Research Foundation hosted Michael Harbut, MD, on our Meet the Mesothelioma Experts (MTME) live broadcast, where he discussed
On Wednesday, July 24, 2019, at 8:00 PM EDT, the Meso Foundation’s Meet the Mesothelioma Experts live broadcast will feature Michael Harbut, MD. Dr. Harbut will
Facebook has recently started harnessing its power for charitable giving with its new Facebook Fundraiser feature. This simple tool allows users to raise money for
Despite initial positive signs from its phase 2 counterpart, the phase 3 LUME-Meso trial in malignant pleural mesothelioma did not meet its primary endpoint of
This Father’s Day weekend, Tina Amigoni Meza, Jason Heil and family will host the third annual Albert Amigoni “Grand Poobah” Open at the Briardale Greens
On Saturday, June 15, Sal Birardi will be competing in the Patriot Half Triathlon in East Freetown, MA. Sal decided to use this 70.3-mile competition
The short answer is: no. Maintenance pemetrexed (Alimta) following standard treatment of pemetrexed (Alimta)/cisplatin does not prolong progression-free survival in patients with pleural mesothelioma. It